We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Stepping stone

19 Mar 2019 By Alec Macfarlane

The U.S. private equity firm is making its Japan LBO debut by acquiring drugmaker Ayumi for $1 bln. It is a retread already owned by two local buyout shops. The government’s newly introduced price controls could squeeze smaller peers, however, and give a rollup strategy a shot.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)